Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update
Go back to Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 3.13 -0.26 (7.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $8.30 | |||
| Open | $3.34 | 52 Week Low | $2.43 | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.09 | EPS | $-0.22 | |||
| Volume | 556,950 | |||||
| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 3.13 -0.26 (7.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $8.30 | |||
| Open | $3.34 | 52 Week Low | $2.43 | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.09 | EPS | $-0.22 | |||
| Volume | 556,950 | |||||

